Construction of a minigenome rescue system for Newcastle disease virus strain Italien

Archives of Virology

Volumn 156, Issue 4, 2011, Pages 611-616

  Feng, Hao ^a   Wei, Ding ^a   Nan, Gang ^a   Cui, Shang Jin ^b   Chen, Zhi Nan ^a   Bian, Huijie ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC VIRUS;

ANIMAL; ARTICLE; CELL LINE; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAMSTER; METHODOLOGY; MICROBIAL GENETICS; NEWCASTLE DISEASE PARAMYXOVIRUS; PLASMID; VIROLOGY; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; CELL LINE; CRICETINAE; GENETICS, MICROBIAL; GENOME, VIRAL; NEWCASTLE DISEASE VIRUS; ONCOLYTIC VIRUSES; PLASMIDS; TRANSFECTION; VIROLOGY; VIRUS REPLICATION;

EUKARYOTA; NEWCASTLE DISEASE VIRUS;

EID: 79953206218     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0898-3     Document Type: Article

References (31)

1. Seal BS, King DJ, Sellers HS (2000) The avian response to Newcastle disease virus. Dev Comp Immunol 24(2-3): 257-268.
2. Krishnamurthy S, Samal SK (1998) Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequence. J Gen Virol 79(Pt 10): 2419-2424.
3. Nakaya T et al (2001) Recombinant Newcastle disease virus as a vaccine vector. J Virol 75(23): 11868-11873.
4. Krishnamurthy S, Huang Z, Samal SK (2000) Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278(1): 168-182.
5. Peeters BP et al (1999) Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73(6): 5001-5009.
6. Kolakofsky D et al (1998) Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol 72(2): 891-899.
7. Peeters BP et al (2000) Genome replication of Newcastle disease virus: involvement of the rule-of-six. Arch Virol 145(9): 1829-1845.
8. Fiola C et al (2006) Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defence. Int J Cancer 119(2): 328-338.
9. Reichard KW et al (1992) Newcastle disease virus selectively kills human tumor cells. J Surg Res 52(5): 448-453.
10. Puhlmann J et al (2010) Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus. Oncogene 29(15): 2205-2216.
11. Bian H et al (2006) In vivo efficacy of systemic tumor targeting of a viral RNA vector with oncolytic properties using a bispecific adapter protein. Int J Oncol 29(6): 1359-1369.
12. Lazar I et al (2009) The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin. J Virol 84(1): 639-646.
13. Yaacov B et al (2008) Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors. Cancer Gene Ther 15(12): 795-807.
14. Lorence RM et al (2007) Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus. Curr Cancer Drug Targets 7(2): 157-167.
15. Freeman AI et al (2006) Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Ther 13(1): 221-228.
16. Lazar I et al (2010) The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin. J Virol 84(1): 639-646.
17. Jiang Y et al (2009) Plasmids driven minigenome rescue system for Newcastle disease virus V4 strain. Mol Biol Rep 36(7): 1909-1914.
18. Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73(1): 251-259.
19. Altomonte J et al (2010) Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma. Mol Ther 18(2): 275-284.
20. Zamarin D et al (2009) Enhancement of oncolytic properties of recombinant Newcastle disease virus through antagonism of cellular innate immune responses. Mol Ther 17(4): 697-706.
21. Vigil A et al (2008) Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Mol Ther 16(11): 1883-1890.
22. Janke M et al (2008) Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2. Int J Oncol 33(4): 823-832.
23. Puhler F et al (2008) Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes. Gene Ther 15(5): 371-383.
24. Freiberg A et al (2008) Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA. Virology 370(1): 33-44.
25. de Wit E et al (2007) A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J Gen Virol 88(Pt 4): 1281-1287.
26. Bailey D et al (2007) Reverse genetics for peste-des-petits-ruminants virus (PPRV): promoter and protein specificities. Virus Res 126(1-2): 250-255.
27. Yan Y et al (2009) Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of Newcastle disease virus. J Virol 83(11): 5943-5946.
28. Wei D et al (2008) Characterization of the genome sequence of an oncolytic Newcastle disease virus strain Italien. Virus Res 135(2): 312-319.
29. Yue H et al (2009) Short hairpin RNA targeting NP mRNA inhibiting Newcastle disease virus production and other viral structural mRNA transcription. Virus Genes 38(1): 143-148.
30. Hasan MK et al (1997) Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J Gen Virol 78(Pt 11): 2813-2820.
31. Wertz GW, Perepelitsa VP, Ball LA (1998) Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus. Proc Natl Acad Sci USA 95(7): 3501-3506.